SLC2A1 and breast neoplasm: While a number of studies suggest that GLUT1 is the predominant glucose transporter expressed in these cells, HR+ breast tumors demonstrate increased expression or translocation of additional GLUT proteins, including GLUTs 1—5, while GLUT12 has been detected at higher levels in ductal cell carcinoma in situ samples [65,66,67,68].